Sylvatica Biotech Inc.
North Charleston, SC
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 4401 Leeds Ave #131, North Charleston, SC 29405, USA
- Website
- sylvaticabio.com
- Founded
- 2015
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Award of sylvatica's DHA sbir phase II enhancement medical R & D contract for "development of a novel cryostasis… | Medical Command (Army) | $549,604 | |
| Army phase I proposal A161-050-0981 | Medical Command (Army) | $100,000 | |
| Sbir phase II DHP 15.1 H2-0185 | Medical Command (Army) | $1,010,000 | |
| DHP sbir 16.1 PH I award | Medical Command (Army) | $150,000 | |
| DHP phase I proposal H151-013-0141 | Medical Command (Army) | $150,000 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Tissue Testing Technologies LLC | North Charleston, SC | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| X-Therma Inc. | Hercules, CA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Expanse Bio LLC | North Charleston, SC | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Desicorp, Inc. | Louisville, KY | 325414 Biological Product (except Diagnostic) Manufacturing |
| NJ Sharing Network | New Providence, NJ | 621991 Blood and Organ Banks |
About the company
Sylvatica Biotech Inc. is a minority-owned, for-profit small business that provides research and development services related to organ and tissue preservation and cryopreservation. According to its website, the company aims to develop solutions to replace organs and tissues on demand to save or improve lives.
Sylvatica has been awarded one prime federal contract, a $549,604 firm fixed price contract from the Department of the Army Medical Command under the Small Business Innovation Research (SBIR) Program Phase II Enhancement. This contract furthers research and development of a novel cryostasis cocktail and protocol to enable high subzero banking of human organs. It builds on prior SBIR Phase I work and will be performed through June 2023 in Charleston, SC.
Through federal grants, Sylvatica provides research and development of technologies for organ preservation and cryopreservation, including of hearts, livers, kidneys, and ovaries. Major funding agencies include the National Institutes of Health (National Heart Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute). Federal grant awards to date total over $5.4 million, with project periods ranging from 2022-2025. Specific topics include perfusion techniques, subzero preservation strategies, fertility preservation, and related solutions to extend organ viability outside the human body for later transplantation.
Quick answers
Is Sylvatica Biotech Inc. registered in SAM.gov?
Yes. Sylvatica Biotech Inc.'s SAM.gov registration is active through July 8, 2027.
What is Sylvatica Biotech Inc.'s CAGE code?
Sylvatica Biotech Inc.'s CAGE code is 7CDY5, and its Unique Entity ID (UEI) is FJJVUJGDDLS3.
What is Sylvatica Biotech Inc.'s most recent federal award?
Sylvatica Biotech Inc.'s most recent federal grant award is Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers (R44DK136457), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on September 17, 2024.
On GovTribe
See Sylvatica Biotech Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors